(Q48002227)

7 February 2018

title

Early versus late hormonal therapy: debating the issues (English)

1 reference

7 February 2018

author name string

E David Crawford

series ordinal

1

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 February 2003

1 reference

7 February 2018

published in

Urology

1 reference

7 February 2018

volume

61

1 reference

7 February 2018

issue

2 Suppl 1

1 reference

7 February 2018

page(s)

8-13

1 reference

7 February 2018

Hormone therapy in advanced prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Treatment options in hormone-refractory prostate cancer: current and future approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Adjuvant therapy of colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Present state and future prospects: a review of cooperative groups' adjuvant and neoadjuvant trials in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Conventional cytotoxic and novel therapeutic concepts in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Adjuvant and neoadjuvant therapy in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Adjuvant mitozantrone chemotherapy in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902394-4

7 January 2021

10.1016/S0090-4295(02)02394-4

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018